10-Q: Natures Sunshine Products Reports Q1 2025 Results: Sales Up, Driven by Asia and Europe
Quarterly Report
Natures Sunshine Products saw a 2.0% increase in consolidated net sales for Q1 2025, driven by growth in Asia and Europe, despite headwinds from foreign exchange rates.
Summary
- Natures Sunshine Products reported a 2.0% increase in consolidated net sales for the first quarter of 2025, reaching $113.2 million compared to $111.0 million in the same period of 2024.
- Excluding the impact of foreign currency exchange rate fluctuations, consolidated net sales increased by 4.5%.
- Asia net sales increased by 5.3% (10.1% in local currencies), with growth in Taiwan and Japan offsetting a slight decrease in South Korea.
- Europe net sales increased by 8.2% (8.6% in local currencies), attributed to improved customer acquisition.
- North America net sales decreased by 4.1% (3.7% in local currencies), primarily due to lower customer acquisition in the United States.
- Latin America and Other net sales decreased by 8.2% (3.7% in local currencies).
- Cost of sales decreased to 27.9% of net sales, compared to 28.8% in the prior year, driven by price increases and cost savings initiatives.
- Selling, general, and administrative expenses decreased to 35.8% of net sales, compared to 36.7% in the prior year, due to streamlining global overhead expenses and reduced service fees in China.
- Net income attributable to common shareholders was $4.747 million, or $0.25 per diluted share, compared to $2.321 million, or $0.12 per diluted share, in the prior year.
- The company repurchased 38,000 shares of its common stock for $0.5 million during the quarter, with $8.3 million remaining available under the share repurchase program.
- The company is conducting an internal investigation regarding past compliance with U.S. trade controls and has made voluntary disclosures to the U.S. Department of Commerce's Bureau of Industry and Security (BIS) and the Office of Foreign Assets Control (OFAC).
Sentiment
Score: 7
Explanation: The report shows positive growth in sales and net income, with successful cost management. However, the ongoing investigation and external risks temper the overall sentiment.
Positives
- Net sales increased by 2.0% compared to the same period last year.
- Asia and Europe segments showed strong growth in net sales.
- Cost of sales as a percentage of net sales decreased, indicating improved efficiency or pricing strategies.
- Selling, general and administrative expenses decreased, suggesting effective cost control.
- Net income attributable to common shareholders increased significantly.
- The company continues to repurchase shares, indicating confidence in its financial position.
- Eastern Europe net sales increased from $14.7 million to $15.8 million.
Negatives
- North America and Latin America segments experienced a decrease in net sales.
- The strengthening of the U.S. dollar negatively impacted net sales by approximately 2.5%.
- The company is undergoing an internal investigation regarding past compliance with U.S. trade controls, which could result in fines or penalties.
- Operating income related to Eastern Europe decreased from $1.6 million to $1.4 million.
Risks
- Fluctuations in foreign currency exchange rates could materially affect sales and costs.
- The ongoing conflict in Eastern Europe is expected to continue impacting the business.
- The internal investigation regarding past compliance with U.S. trade controls could result in fines or penalties.
- Inflationary pressures may adversely impact operations through higher costs of raw materials, labor, and distribution.
- Changes in U.S. trade policy, including tariffs, may have a material adverse effect on the business.
- The company acknowledges risks associated with social, political, and economic conditions in international operations.
Future Outlook
The company expects foreign markets to continue representing a substantial portion of overall sales and related operating expenses, and that the conflict in Eastern Europe will continue to impact the business for the foreseeable future.
Industry Context
The direct selling industry is highly competitive and subject to changing consumer preferences and economic conditions; Natures Sunshine Products faces competition from other direct selling companies, as well as traditional retail channels.
Comparison to Industry Standards
- It's difficult to provide a precise comparison without knowing the specific competitors and industry benchmarks used by Natures Sunshine Products.
- However, a general comparison can be made to other companies in the nutritional and personal care products industry, such as Herbalife Nutrition, Nu Skin Enterprises, and USANA Health Sciences.
- These companies also rely on direct selling models and operate globally.
- Comparing Natures Sunshine's growth rate, profitability, and financial metrics to these companies would provide a better understanding of its performance relative to industry standards.
- For example, Herbalife reported net sales of $1.3 billion in Q1 2024, while Nu Skin reported revenue of $495.4 million.
- Natures Sunshine's $113.2 million in net sales is significantly lower than these larger competitors, but its growth rate and profitability may be comparable or different depending on the specific market conditions and business strategies.
Legal Proceedings
- The company is a party to various legal proceedings and disputes in the United States and foreign jurisdictions.
- The company is undergoing an internal investigation regarding past compliance with U.S. trade controls and has made voluntary disclosures to the U.S. Department of Commerce's Bureau of Industry and Security (BIS) and the Office of Foreign Assets Control (OFAC).
Stakeholder Impact
- Shareholders will likely react positively to the increased net income and sales growth.
- Independent consultants in Asia and Europe may benefit from the sales growth in those regions.
- Employees may be affected by the streamlining of global overhead expenses.
- Customers may be impacted by price increases implemented to offset inflationary pressures.
Next Steps
- Continue monitoring the social, political, regulatory and economic environment in Ukraine and Russia.
- Continue the internal investigation regarding past compliance with relevant U.S. trade controls.
- Monitor and adapt to changes in U.S. trade policy, including tariffs.
- Focus on managing inflationary pressures and mitigating their impact on operations.
Key Dates
| Date | Description |
|---|---|
| 2012-12-31 | Shareholders adopted and approved the 2012 Incentive Plan |
| 2017-07-11 | Entered into a revolving credit agreement with Bank of America, N.A. |
| 2021-03-10 | Announced a $15.0 million common share repurchase program. |
| 2021-05-05 | Shareholders approved the Amended and Restated 2012 Stock Incentive Plan. |
| 2022-03-08 | Announced an amendment to the share repurchase program allowing the repurchase of an additional $30.0 million in common shares. |
| 2022-06-23 | The Credit Agreement was amended to extend the term to mature on July 1, 2027. |
| 2024-09-11 | The Credit Agreement was amended to modify the calculation of interest. |
| 2024-11 | Began an internal investigation regarding past compliance with relevant U.S. trade controls and made voluntary disclosures of apparent trade controls violations to the U.S. Department of Commerce's Bureau of Industry and Security (BIS). |
| 2025-03-31 | End of the quarterly period. |
| 2025-04 | Filed a voluntary self-disclosure with the Office of Foreign Assets Control relating to the same internal investigation. |
| 2025-04-18 | The number of shares of Common Stock, no par value, outstanding was 18,350,801 shares. |
| 2025-05-06 | Date of report filing. |
Keywords
net sales, financial results, Q1 2025, Natures Sunshine Products, Asia, Europe, share repurchase, trade controls, internal investigation, foreign exchange
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.